CCR2 and neoplasm: However, the repeated treatment with of the CCR2-Ig not only further suppressed luciferase activity (Figure 4B, C, p<0.01), but also led to a significant inhibition in tumor size (Figure 4A, day 65, 227±19 compared to 770±65 mm3, p<0.001).